Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,813 | 8,586 | 6,707 | 0 | 0 |
| Receivables | 208 | 206 | 131 | 0 | 0 |
| TOTAL | $6,680 | $9,648 | $7,853 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 951 | 84 | 90 | N/A | N/A |
| Intangibles | 2,430 | 2,570 | 2,709 | 0 | 0 |
| Other Non-Current Assets | 196 | 19 | 19 | 0 | 0 |
| TOTAL | $3,577 | $2,673 | $2,818 | $N/A | $N/A |
| Total Assets | $10,257 | $12,321 | $10,671 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,646 | 1,456 | 1,498 | 0 | 0 |
| Other current liabilities | 310 | 477 | 625 | 0 | 0 |
| TOTAL | $2,629 | $2,294 | $2,440 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 266 | 361 | 317 | N/A | N/A |
| Other Non-Current Liabilities | 287 | 78 | 88 | 34 | 21 |
| TOTAL | $221 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,850 | $2,294 | $2,440 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,069 | 1,069 | N/A | N/A | N/A |
| Common Shares | 4 | 4 | 4 | 0 | 0 |
| Retained earnings | -80,276 | -77,187 | -74,054 | 0 | 0 |
| Other shareholders' equity | 704 | 730 | 782 | 0 | 0 |
| TOTAL | $7,407 | $10,027 | $8,231 | $0 | $0 |
| Total Liabilities And Equity | $10,257 | $12,321 | $10,671 | $0 | $0 |